|Bid||0.00 x 1000|
|Ask||0.00 x 900|
|Day's Range||8.58 - 8.74|
|52 Week Range||3.88 - 13.51|
|Beta (5Y Monthly)||2.41|
|PE Ratio (TTM)||N/A|
|Earnings Date||Dec 20, 2021 - Dec 27, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||14.00|
Subscribe to Yahoo Finance Plus to view Fair Value for VNCELearn more
Vince Holding Corp. ( NYSE:VNCE ) shareholders should be happy to see the share price up 20% in the last month. But...
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic atrophy. IVERIC Bio, a competitor to Apellis, is also working on a product to treat geographic atrophy, called Zimura. Stifel initiated coverage on IVERIC bio with a Buy rating and announced a price target of $22. Echo Global Logistics, Inc. (NASDAQ: ECHO) surged 53.8% to $48.16 after the company agreed to be acquired by priva
Vince Holding Corp. (VNCE) delivered earnings and revenue surprises of 92.19% and 11.44%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stock?